DJIA 16,507.31 -7.06 -0.04%
NASDAQ 4,132.24 -29.22 -0.70%
S&P 500 1,876.02 -3.53 -0.19%
market minute promo

Novavax, Inc.

NASDAQ: NVAX

4.17 -0.15 (-3.36%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NVAX $4.17 -3.36%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.34
Previous Close $4.31
Daily Range $4.07 - $4.36
52-Week Range $1.68 - $6.95
Market Cap $870.7M
P/E Ratio -13.90
Dividend (Yield) $0.00 (0.0%)
Volume 1,772,519
Average Daily Volume 5,175,039
Current FY EPS -$0.27

Sector

Healthcare

Industry

Drugs

Novavax, Inc. (NVAX) Description

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases. Website: http://www.novavax.com/

News & Commentary Rss Feed

Are Inovio and Rockwell Medical In for a Bad Year?

These biopharmas have started the year poorly and could be in for a bad 2014.

Stock To Watch: Novavax (NVAX) In Perilous Reversal

Novavax: Promising Pipeline And Stable Revenue Add To Upside

Today's Dead Cat Bounce Stock: Novavax (NVAX)

Insiders And Analysts Like These Speculative Small Cap Stocks

5 Stocks With Big Insider Buying

Insider Trading Alert - UNP, OPK And NVAX Traded By Insiders

Novavax Is Now Oversold (NVAX)

Benzinga's Top #PreMarket Gainers

Novavax's CEO Discusses Q4 2013 Results - Earnings Call Transcript

After-Hours Earnings Report for March 10, 2014 : URBN, UNFI, CASY, NVAX, SMLP, PWRD, FCEL, EXK, POW

After-Hours Earnings Report for March 10, 2014 : URBN, UNFI, CASY, NVAX, SMLP, PWRD, FCEL, EXK, POWR, CISG, MED, PLOW

See More NVAX News...

NVAX's Top Competitors

NVAX $4.17 (-3.36%)
Current stock: NVAX
AMGN $113.21 (-5.10%)
Current stock: AMGN
GILD $74.17 (1.80%)
Current stock: GILD
BIIB $305.64 (-0.18%)
Current stock: BIIB